Literature DB >> 2995822

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses.

I M Chiu, A Yaniv, J E Dahlberg, A Gazit, S F Skuntz, S R Tronick, S A Aaronson.   

Abstract

Lentiviruses are a subfamily of retroviruses which have been aetiologically linked to the induction of arthritis, encephalitis, progressive pneumonia and slow neurological diseases in certain species. Relatively little is known about their genome structure, mechanisms of pathogenesis or evolutionary relationships with other retroviral subfamilies. In an effort to understand better the mechanisms by which these viruses induce such a variety of chronic diseases, we have molecularly cloned and physically characterized the genomes of caprine arthritis-encephalitis virus (CAEV) and equine infectious anaemia virus (EIAV) (A.Y. et al., in preparation). The latter, which bears some morphological similarity to the lentiviruses, has yet to be classified definitively as one. Here, we have determined the nucleotide sequence of a highly conserved region within the CAEV and EIAV pol genes. We demonstrate a much closer relationship of their predicted pol gene products to that of the presumed aetiological agent of human acquired immune deficiency syndrome (AIDS) than to those of other retroviruses. Additional pairwise comparisons allowed us to generate an evolutionary tree showing that the pol genes of lentiviruses and oncoviruses have evolved from a common progenitor.

Entities:  

Mesh:

Year:  1985        PMID: 2995822     DOI: 10.1038/317366a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  59 in total

1.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

2.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report.

Authors:  Y Kono
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins.

Authors:  M J Braun; J E Clements; M A Gonda
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Comparative analysis of the retroviral pol and env protein sequences reveal different evolutionary trees.

Authors:  G Lewe; R M Flügel
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

6.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells.

Authors:  E Priel; S D Showalter; M Roberts; S Oroszlan; D G Blair
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Augmentation of lymphocyte and macrophage proliferation by caprine arthritis-encephalitis virus contributes to the development of progressive arthritis.

Authors:  K L Banks; M A Jutila; C A Jacobs; F H Michaels
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

9.  Viral DNA in horses infected with equine infectious anemia virus.

Authors:  N R Rice; A S Lequarre; J W Casey; S Lahn; R M Stephens; J Edwards
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Proviral sequences detected by polymerase chain reaction in peripheral blood cells of horses with equine infectious anemia lentivirus.

Authors:  K I O'Rourke; M L Besola; T C McGuire
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.